SG11202112856QA - Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer - Google Patents

Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer

Info

Publication number
SG11202112856QA
SG11202112856QA SG11202112856QA SG11202112856QA SG11202112856QA SG 11202112856Q A SG11202112856Q A SG 11202112856QA SG 11202112856Q A SG11202112856Q A SG 11202112856QA SG 11202112856Q A SG11202112856Q A SG 11202112856QA SG 11202112856Q A SG11202112856Q A SG 11202112856QA
Authority
SG
Singapore
Prior art keywords
substituted
compound
alkylc
alkoxy
hydroxy
Prior art date
Application number
SG11202112856QA
Other languages
English (en)
Inventor
Jonathan Sessler
Sajal Sen
Jonathan Arambula
Zhengrong Cui
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of SG11202112856QA publication Critical patent/SG11202112856QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/12—Gold compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/10—Silver compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202112856QA 2019-05-22 2020-05-22 Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer SG11202112856QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962851187P 2019-05-22 2019-05-22
PCT/US2020/034415 WO2020237225A1 (en) 2019-05-22 2020-05-22 Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
SG11202112856QA true SG11202112856QA (en) 2021-12-30

Family

ID=73459479

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112856QA SG11202112856QA (en) 2019-05-22 2020-05-22 Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer

Country Status (11)

Country Link
US (1) US12577262B2 (https=)
EP (1) EP3972981A4 (https=)
JP (1) JP2022532801A (https=)
KR (1) KR20220024123A (https=)
CN (1) CN114174305A (https=)
AU (1) AU2020279478A1 (https=)
CA (1) CA3140716A1 (https=)
IL (1) IL288176A (https=)
MX (1) MX2021014195A (https=)
SG (1) SG11202112856QA (https=)
WO (1) WO2020237225A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201003483D0 (en) * 2010-03-02 2010-04-14 Univ St Andrews Gold complexes
US8900654B2 (en) * 2011-07-29 2014-12-02 Thin Film Electronics, Inc. Methods of polymerizing silanes and cyclosilanes using N-heterocyclic carbenes, metal complexes having N-heterocyclic carbene ligands, and lanthanide compounds
HUE033704T2 (en) 2012-02-13 2017-12-28 Bristol Myers Squibb Co Enediyne compounds, conjugates thereof, and uses and methods therefor
US20170129911A1 (en) 2015-11-10 2017-05-11 Massachusetts Institute Of Technology Complexes comprising a platinum compound and an immune checkpoint inhibitor and related methods
WO2019006327A1 (en) * 2017-06-30 2019-01-03 Board Of Regents, The University Of Texas System OR-CARBENE COMPLEXES CONTAINING NAPHTOQUINONE AND METHODS OF USE

Also Published As

Publication number Publication date
EP3972981A4 (en) 2023-05-24
CA3140716A1 (en) 2020-11-26
KR20220024123A (ko) 2022-03-03
EP3972981A1 (en) 2022-03-30
US12577262B2 (en) 2026-03-17
AU2020279478A1 (en) 2021-12-09
CN114174305A (zh) 2022-03-11
WO2020237225A1 (en) 2020-11-26
IL288176A (en) 2022-01-01
JP2022532801A (ja) 2022-07-19
MX2021014195A (es) 2022-02-21
US20220340601A1 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
US12472187B2 (en) Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
CN116917288B (zh) 一种7,9-二氢嘌呤衍生物及其制药用途
CN103748080A (zh) 喹唑啉衍生物类酪氨酸激酶抑制剂及其制造方法与应用
KR20240021239A (ko) Cdk 키나아제 억제제로 사용되는 화합물 및 이의 용도
CN104163823B (zh) 一种喜树碱与青蒿琥酯偶联物及其制备方法与应用
TW201922709A (zh) 表皮生長因子受體抑制劑
NO324594B1 (no) Nye indolderivater, fremgangsmate for fremstilling derav og deres anvendelse og medikamenter inneholdende derivatene.
CN107556361A (zh) 裂环羽扇豆烷衍生物及其抗肿瘤用途
WO2018086242A1 (zh) pH敏感的轴向取代硅酞菁配合物及其制备方法和在医药上的应用
CN118320117B (zh) 多细胞器靶向、原位释放的分子基药物递送系统
SG11202112856QA (en) Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer
CN103804388B (zh) 4β-氮取代呋喃叔胺类鬼臼毒素衍生物及其制备方法与应用
US9499552B2 (en) Pyrazolo[1,5-A]pyrimidine derivative and use of anti-tumor thereof
WO2012139487A1 (zh) 喜树碱类化合物的聚乙二醇化衍生物
CN114874245A (zh) 一种二硫代氨基甲酸金属配合物的前药化合物及其制备方法与应用
CN112500412A (zh) 一种Peganumine A生物碱结构简化物及应用
CN113493414A (zh) 一种氘代取代丁烯酰胺及其制备方法与应用
CN116003478B (zh) 一类含有鸟嘌呤衍生物配体的三联吡啶-铂（ii）新型配合物及其制备方法和应用
CN118994161B (zh) 一种(s)-2-(4-(4-甲基-1-哌嗪基)苯胺基)-8-苯胺基-9-(3-哌啶基)-9h-嘌呤及其应用
CN114057696B (zh) 一种咔唑-嘧啶衍生物及其制备方法和应用
CN120098064A (zh) 一种src-3 protac化合物及其制备方法和在治疗乳腺癌中的应用
EP4700034A1 (en) Metal complex compounds, conjugates and conjugatable compounds therefrom as well as uses thereof and processes of producing the same
CN121779384A (zh) 一种烟酰胺衍生物及其制备方法和应用
CN121930257A (zh) 一类含二氧杂环丁烷的金(ⅲ)配合物及其制备方法和应用
KR101713678B1 (ko) 신규 화합물 4-Ethyl-7-(2-fluoro-benzylsulfanyl)-2-methyl-1-thia-3b, 5, 6-triaza-cyclopenta[a]indene 및 이를 포함하는 항암제용 약제학적 조성물